Literature DB >> 22233043

[The effect of total phenolics from abnormal savda munziq on cervical cancer cell lines].

Ke-Yao Chen1, Ablimit Tangnur, Guo-Ning Wang, Abliz Guzalnur.   

Abstract

OBJECTIVE: To explore the feasibility of total phenolics from Abnormal Savda Munziq on treating human cervical carcinoma.
METHODS: MTT assay was used to determine the growth inhibition ratio and IC50 on Hela cells and SiHa cells after treated with different concentrations of total phenolics. Morphologic changes of cells were observed by inverted microscope.
RESULTS: Total phenolics inhibited the proliferation of Hela cells in the concentration range of 25 - 125 microg/mL; Total phenolics inhibited the proliferation of SiHa cells in the concentration range of 75 - 175 microg/mL; The inhibitory actions of total phenolics on the Hela and SiHa appeard dose-effect relationship and time-effect relationship obviously (P < 0.01); The IC50 of Hela was (125.26 +/- 16.15) microg/mL after 48h total phenolics treatment; The IC50 of SiHa was (134.51 +/- 2.55) microg/mL after 48h total phenolics treatment. And there was no statistical sense in the disparation of them (P > 0.05); Both of the cells showed apoptosis character evidently after total phenolics treatment, Along with the increasing of the concentration and the action time, morphologic changes of cells were more obviously.
CONCLUSION: Total phenolics could inhibit the growth of Hela cells and SiHa cells and the inhibitory actions of total phenolics on the two cells is almostly the same. Therefore, total phenolics from abnormal savda munziq is deserved to be further studied for treating human cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22233043

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  1 in total

1.  Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine.

Authors:  Tao Yang; Mutalifu Aimaiti; Deqi Su; Weiwei Miao; Bin Zhou; Dilinuer Maimaitiyiming; Abdiryim Yusup; Halmurat Upur; Ainiwaer Aikemu
Journal:  BMC Complement Altern Med       Date:  2017-04-07       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.